RO7507062
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO7507062, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus [Phase 1]